| Christina Rose Andreoli, APRN | |
|
24 Woodvale Rd, Branford, CT 06405-3953 | |
| (203) 687-8600 | |
| Not Available |
| Full Name | Christina Rose Andreoli |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 24 Woodvale Rd, Branford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821757832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 9712 (Connecticut) | Primary |
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
ARIAD Pharmaceuticals, Inc. today announced the initiation of a multi-center Phase 1/2 clinical trial in Japan of ponatinib, the Company's investigational BCR-ABL inhibitor.
Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received approval for SUPRAX (Cefixime) Capsules 400 mg from the United States Food and Drugs Administration (FDA).
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
For the first time in alcohol addiction research, UVA investigators have successfully treated alcohol-dependent individuals with medication that is tailored specifically to match their genetic profile.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Rose Andreoli, APRN 24 Woodvale Rd, Branford, CT 06405-3953 Ph: (203) 687-8600 | Christina Rose Andreoli, APRN 24 Woodvale Rd, Branford, CT 06405-3953 Ph: (203) 687-8600 |
News Archive
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
ARIAD Pharmaceuticals, Inc. today announced the initiation of a multi-center Phase 1/2 clinical trial in Japan of ponatinib, the Company's investigational BCR-ABL inhibitor.
Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received approval for SUPRAX (Cefixime) Capsules 400 mg from the United States Food and Drugs Administration (FDA).
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
For the first time in alcohol addiction research, UVA investigators have successfully treated alcohol-dependent individuals with medication that is tailored specifically to match their genetic profile.
› Verified 3 days ago
Ms. Maura Jane D'andrea, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 19 Ozone Rd, Branford, CT 06405 Phone: 203-488-4301 | |
Barbara A Moynihan, PH.D, APRN,BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 S Main St, Branford, CT 06405 Phone: 888-616-8563 Fax: 203-481-4217 | |
Mrs. Shelli Leore Feder, MSN FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Double Beach Rd, Branford, CT 06405 Phone: 937-239-2801 | |
Mrs. Shawn Polizzi, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1090 Main St, Branford, CT 06405 Phone: 203-848-8704 | |
Jennifer Goldfuss, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 420 East Main St Building #2 Suite #5, Branford, CT 06405 Phone: 203-433-2550 | |
Mrs. Nicole J Marfino, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 W Main St, Branford, CT 06405 Phone: 203-483-7778 | |
Beth Robins Roth, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Montowese St Ste 5, Branford, CT 06405 Phone: 203-824-1249 |